Business
Investor Presentation via Engage Investor
Roquefort Therapeutics PLC will host a live interactive presentation on the Engage Investor platform on September 29, 2025, at 4pm BST. The presentation aims to update investors on the proposed acquisition of Coiled Therapeutics, Inc. and its AO-252 clinical stage program from A2A Pharma. The company encourages current shareholders and interested investors to join the presentation and pre-submit questions via the Engage Investor platform. Disclaimer*
About this update from Coiled Therapeutics Plc
[{"type":"text","content":"\n\n24 September 2025\n \nRoquefort Therapeutics plc\n(\"Roquefort Therapeutics\" or the \"Company\")\nInvestor Presentation via Engage Investor\nRoquefort Therapeutics (LSE:ROQ), the Main Market listed biotech company, announces that the Company's Chairman Stephen West alongside Edward Painter and Sridhar Vempati, Chairman and Chief Strategy Officer respectively of A2A Pharmaceuticals, Inc. (\"A2A Pharma\") will host a live interactive presentation on the Engage Investor platform on Monday, 29 September 2025 at 4pm BST.\nThe objective of the presentation is to provide investors with an update relating to the proposed acquisition of Coiled Therapeutics, Inc. and its AO-252 clinical stage program from A2A Pharma.\nAll current shareholders and interested investors are invited to join and investors are encouraged to pre-submit questions via the Engage Investor platform. Investors can also submit questions at any time during the live presentation.\nInvestors can sign up to Engage Investor at no cost and follow Roquefort Therapeutics from their personalised investor hub.\nRegister interest in this event here:\nhttps://engageinvestor.news/ROQ_IP_0925\nENDS\nEnquiries:\n\n\n\n\nRoquefort Therapeutics plc\n\n\n+44 (0)20 3918 8633\n\n\n\n\nStephen West (Chairman) / Dr Darrin Disley (Interim MD)\n\n\n\n\n\n\n\nSP Angel Corporate Finance LLP (Broker to the Company)\nDavid Hignell / Vadim Alexandre / Devik Mehta\n\n\n+44 (0)20 3470 0470\n \n\n\n\n\nCPS Capital (Broker to A2A Pharmaceuticals)\nJason Peterson / David Valentino\n\n\n+61 (0)8 9223 2222\n\n\n\n\nBurson Buchanan (Public Relations)\nBen Romney / Jamie Hooper\n\n\n+44 (0)20 7466 5000\n \n\n\n\n\nPeak IR (Investor Relations)\nSeb Wykeham\n\n\n+33 (0)7 44 44 15 42\n\n\n\n\n \nLEI: 254900P4SISIWOR9RH34\n \nFor further information on Roquefort Therapeutics, please visit www.roquefortplc.com and @RoquefortTherap on X (formerly Twitter)\n \n\n","length":5094,"tagName":"div"}]